Abstract:For many years, sustained-release drug delivery systems (SRDDS) have emerged as a featured topic in the pharmaceutical field. Particularly for chronic diseases, such as osteoarthritis, there is a lot of demand for SRDDS because of the long treatment period and repetitive medication administration. Thus, we developed an injectable PLGA-F127 microsphere (MS) that is capable of the in situ conversion to an implant. The microprecipitation method for PLGA-F127 MS was established, and the physicochemical stability of the products was confirmed. The microspheres were assembled into a single mass in 37 °C aqueous conditions and showed a remarkably delayed drug release profile. First, the release started with no significant initial burst and lagged for 60 days. After that, in the next 40 days, the remaining 75% of the drugs were constantly released until day 105. We expect that our PLGA-F127 MS could be employed to extend the release period of 2 months of medication to 4 months. This could be a valuable solution for developing novel SRDDS for local injections.

What problem does this paper attempt to address?

The paper mainly addresses the following issues: ### Research Background and Objectives - **Background**: For chronic diseases such as osteoarthritis (OA), the long treatment cycles and repeated medication requirements make sustained-release drug delivery systems (SRDDS) a research hotspot. Particularly, intra-articular injection-based sustained-release drug delivery systems can effectively control pain and reduce inflammatory responses. - **Objectives**: To develop a long-acting, controlled-release intra-articular injection material to reduce the side effects of high-dose corticosteroids and extend the duration of drug action. ### Solution - **Innovation**: Researchers have developed a self-assembling microsphere (MS) based on poly(lactic-co-glycolic acid) (PLGA) and Pluronic F127 for the sustained drug delivery in osteoarthritis. These microspheres can transform into an implant form in vivo, achieving sustained drug release. ### Key Technologies and Findings 1. **Microsphere Preparation**: Different formulations of PLGA-F127 microspheres were successfully prepared using the micro-precipitation method. Experiments showed that formulations containing an appropriate amount of F127 could form uniformly dispersed microspheres, and these microspheres could self-assemble into a single mass in a 37°C aqueous solution. 2. **Drug Loading and Stability**: Scanning electron microscopy (SEM), X-ray diffraction (XRD), and differential scanning calorimetry (DSC) confirmed that dexamethasone (DXA) was successfully encapsulated in the PLGA-F127 microspheres and exhibited an amorphous state, which helps improve drug stability and bioavailability. 3. **In Vitro Drug Release Characteristics**: Compared to blank microspheres, the drug-loaded PLGA-F127 microspheres exhibited a significantly delayed biphasic release pattern, with an initial slow release followed by sustained release for up to 105 days, indicating their potential to extend the duration of drug action. 4. **Self-Assembly Behavior**: At 37°C, PLGA-F127 microspheres rapidly formed aggregates and completely degraded after 120 days; whereas at room temperature, the microspheres remained dispersed with no aggregation observed. ### Discussion - **Advantages of Preparation Method**: Compared to the traditional microemulsion method, the micro-precipitation method can more effectively prevent microsphere aggregation, forming more uniform particles. However, this method still has some limitations, such as low yield and encapsulation efficiency. - **Future Work**: The authors believe that further optimization of parameters such as microsphere size can improve the final product yield. Despite some shortcomings, the potential value of PLGA-F127 microspheres as a sustained-release drug delivery system is still worth exploring. In summary, this study proposes a novel sustained-release drug delivery system aimed at improving the drug release pattern in osteoarthritis treatment, thereby reducing the frequency of medication and minimizing side effects for patients.

Self-Assembled PLGA-Pluronic F127 Microsphere for Sustained Drug Release for Osteoarthritis

Resveratrol-Loaded Poly(d,l-Lactide-Co-Glycolide) Microspheres Integrated in a Hyaluronic Acid Injectable Hydrogel for Cartilage Regeneration

An in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics

Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles

Novel poly(lactic-co-glycolic acid) nanoliposome-encapsulated diclofenac sodium and celecoxib enable long-lasting synergistic treatment of osteoarthritis

Multifunctional injectable microspheres for osteoarthritis therapy via spatiotemporally modulating macrophage polarization and inflammation

Injectable Alginate Microsphere/plga–peg–plga Composite Hydrogels for Sustained Drug Release

PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo

Preparation and characterization of poly (lactic-co-glycolic acid) microspheres for controlled release of osteogenic growth peptide

High drug loading hydrophobic cross-linked dextran microspheres as novel drug delivery systems for the treatment of osteoarthritis

Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam

Biomimetic injectable hydrogel microspheres with enhanced lubrication and controllable drug release for the treatment of osteoarthritis

An injectable self-lubricating supramolecular polymer hydrogel loaded with platelet lysate to boost osteoarthritis treatment

PLGA porous microspheres enhancing the osteogenesis of MC 3 T 3E 1 cells

Sustained-Drug-Release, Strong, and Anti-Swelling Water-Lipid Biphasic Hydrogels Prepared via Digital Light Processing 3D Printing for Protection against Osteoarthritis: Demonstration in a Porcine Model

PLGA Microspheres Prepared Via Aqueous-aqueous Emulsification for Pulsed Drug Delivery

Porous Core/Dense Shell PLA Microspheres Embedded with High Drug Loading of Bupivacaine Crystals for Injectable Prolonged Release

Intra-articular injection PLGA blends sustained-release microspheres loaded with meloxicam: preparation, optimization, evaluation in vitro and in vivo

Novel Preparation Method for Sustained-Release Plga Microspheres Using Water-In-Oil-In-Hydrophilic-Oil-In-Water Emulsion

Microfluidic-Based Preparation of Plga Microspheres Facilitating Peptide Sustained-Release

Enhancing Alendronate Release from a Novel PLGA/hydroxyapatite Microspheric System for Bone Repairing Applications.